Bangladesh Society of Interventional Neurologist

26/12/2025

09 pm Tonight.
Join Zoom Meeting
https://us02web.zoom.us/j/81435008487?pwd=jlWmOja1KH1OmrzKx5ekXjOmYvh9fY.1

Meeting ID: 814 3500 8487
Passcode: ESKAYEF

23/08/2025

Newer FDA approved Treatment for Alzheimer's Disease

*Anti-Amyloid Treatments*
These newest treatments to fight Alzheimer’s disease are immunotherapies targeting toxic amyloid-beta proteins that form plaques in the brain, a defining feature of the disease. Removing amyloid-beta from the brain reduces cognitive and functional decline in people living with early Alzheimer’s. Talk with your clinician about the risks and side effects associated with drugs in this class.

**KisunlaTM* (donanemab-azbt)*

FDA status: Approved in 2024.*

How it works: Kisunla is a type of amyloid immunotherapy drug* which targets a plaque-specific form of amyloid that is highly toxic and increases amyloid aggregation. In a phase 3 clinical trial, it slowed the progression of cognitive and functional decline by 35% in participants with early signs of Alzheimer’s disease, with 76.4% of participants showing amyloid clearing with PET imaging.

Delivery method: Administered intravenously (through a vein); in clinical trials, treatment was administered *every four weeks for up to 72 weeks.*

Side effects: In the phase 3 trial, common side effects included amyloid-related imaging abnormalities (ARIA), headache, and infusion-related reactions.

12/08/2025

*New treatment addresses multiple aspects of MND*
Motor neurone disease, which affects over 5,000 people in the *UK* at any given time, is characterised by progressive muscle wasting.

Current treatments only address symptoms, but *Ellorarxine* shows potential to tackle the underlying causes of the disease.

The study revealed that Ellorarxine demonstrates antioxidant and anti-inflammatory effects, even at very low concentrations.

It was found to increase the expression of key proteins, promote neurite growth, and improve mitochondrial health – all crucial factors in combating MND.

What sets Ellorarxine apart is its ability to address what researchers call the "3Ns" – neuroprotection, neuroplasticity, and neurorepair. This comprehensive approach is rare in potential MND treatments and could be a game-changer in the field.
Source: A study by Durham University

09/01/2025

Short Cases in Clinical Neurology... 3rd edition

05/09/2024

By the grace of Almighty My fourth text book "Basics of EEG". This is the first EEG book in Bangadesh. The book has been published September 2024.

10/03/2024

It's a privilege for me to receive a research grant by the Ministry of Science and Technology from the Honourable Prime Minister Sheikh Hasina at the Prime Minister Office . Time: 9AM, 11March 2024. A live telecast will be done.

09/01/2024

https://youtu.be/FmEgcud1AlA?si=Sakaq_hMtoGHj2ZC

23/12/2023

International Conference on AI Technology.. Abstract

14/09/2023

06/01/2023

By the grace of Almighty my 3rd text book " Fundamentals in Clinical neurology" First edition has been published. It provides a simplified approach to neurology assessment in examinations and recent update of management and recent updates of neurology for the doctors, students, and residents of MD (Neurology/Medicine), MS (Neurosurgery), FCPS (Neurology/Medicine/Neurosurgery) , FRCP, FRCS, and PACES in MRCP, the MRCS examination in the UK, and the USMLE .

09/01/2022

Alhamdulliah. By the grace of Almighty, my "Neuroimaging in Clinical Practice- Second Edition." has been published.
Key features of this book are:
****High yield information of neuroimaging is emphasized throughout the text for easy retention.
**** It offers in a simplified way of approach to the assessment neuroimagings in the examinations like MD (Neurology / Radiology/ Internal Medicine), MS (Neurosurgery), FCPS (Neurology / Internal Medicine / Neurosurgery / Radiology), FRCP, FRCS and PACES in MRCP, MRCS examination in UK & USMLE for the very first time or those preparing to recertify.
***Newly - For examination or self assessment OSPE/ SBA (FCPS- Medicine/ Neurology/ Neurosurgery/Radiology) are included with answers after the end of chapters.
Sole distributor: PG Medical Books, Nilkhet, Dhaka.